ATE505486T1 - Rezeptor für das menschliche follikel- stimulierende hormon - Google Patents

Rezeptor für das menschliche follikel- stimulierende hormon

Info

Publication number
ATE505486T1
ATE505486T1 AT01202809T AT01202809T ATE505486T1 AT E505486 T1 ATE505486 T1 AT E505486T1 AT 01202809 T AT01202809 T AT 01202809T AT 01202809 T AT01202809 T AT 01202809T AT E505486 T1 ATE505486 T1 AT E505486T1
Authority
AT
Austria
Prior art keywords
receptor
mutant
fragment
fsh
present
Prior art date
Application number
AT01202809T
Other languages
English (en)
Inventor
Christie Ann Kelton
Shirley Vui Yen Cheng
Noreen Patrice Nugent
Rene Lynn Schweickhardt
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24688922&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE505486(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Application granted granted Critical
Publication of ATE505486T1 publication Critical patent/ATE505486T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
AT01202809T 1991-03-15 1992-01-02 Rezeptor für das menschliche follikel- stimulierende hormon ATE505486T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67008591A 1991-03-15 1991-03-15

Publications (1)

Publication Number Publication Date
ATE505486T1 true ATE505486T1 (de) 2011-04-15

Family

ID=24688922

Family Applications (2)

Application Number Title Priority Date Filing Date
AT92904833T ATE224446T1 (de) 1991-03-15 1992-01-02 Menschlicher rezeptor für das follikel- stimulierendes hormon.
AT01202809T ATE505486T1 (de) 1991-03-15 1992-01-02 Rezeptor für das menschliche follikel- stimulierende hormon

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT92904833T ATE224446T1 (de) 1991-03-15 1992-01-02 Menschlicher rezeptor für das follikel- stimulierendes hormon.

Country Status (19)

Country Link
US (3) US6121016A (de)
EP (2) EP0575357B1 (de)
JP (1) JP3581148B2 (de)
KR (1) KR100245250B1 (de)
AT (2) ATE224446T1 (de)
AU (1) AU671417B2 (de)
CA (1) CA2106061C (de)
DE (2) DE69232779T2 (de)
DK (1) DK0575357T3 (de)
ES (1) ES2183806T3 (de)
FI (1) FI109360B (de)
GE (1) GEP19991604B (de)
LT (1) LT3973B (de)
LV (1) LV10724B (de)
MX (1) MX9203350A (de)
NO (1) NO315517B1 (de)
RU (1) RU2193599C2 (de)
UA (1) UA43826C2 (de)
WO (1) WO1992016620A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3949893A (en) * 1992-03-30 1993-11-08 Akzo Nobel N.V. Human gonadotropin receptor (FSH receptor)
SI0894141T1 (en) 1996-02-20 2005-10-31 Applied Research Systems Ars Holding N.V. Hybrid proteins which form heterodimers
US5925549A (en) * 1996-04-15 1999-07-20 The Board Of Trustees Of The Leland Stanford Junior University Soluble 7-transmembrane domain G-protein-coupled receptor compositions and methods
US6521641B1 (en) 1998-10-08 2003-02-18 Allergan, Inc. Male anti-fertility agents
AU5137900A (en) * 1999-05-28 2000-12-18 University Of Cincinnati, The Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use
EP1287135A2 (de) * 2000-05-18 2003-03-05 Bayer Aktiengesellschaft Regulation eines menschlichen, follikel-stimulierenden hormon-ähnlichen g-protein gekoppelten rezeptors
WO2003062396A2 (en) * 2002-01-23 2003-07-31 Arena Pharmaceuticals, Inc. Non-endogenous versions of human g protein-coupled receptor: fshr
EP1466620A1 (de) * 2003-04-11 2004-10-13 AXXAM S.r.l. Modulatoren des Follikel-stimulierenden Hormon-Rezeptors und ihre therapeutische Verwendung
US20100061976A1 (en) * 2008-07-24 2010-03-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652450A (en) 1984-08-31 1987-03-24 Research Corporation Bacterial FSH binding inhibitor
US4761371A (en) 1985-02-12 1988-08-02 Genentech, Inc. Insulin receptor
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US4921808A (en) * 1986-06-25 1990-05-01 The Albany Medical College Of Union University Method for determining follicle stimulating hormone
US4960700A (en) * 1986-12-24 1990-10-02 Genentech, Inc. Compositions and methods for the synthesis and assay of a mammalian enkephalinase
EP1199361A3 (de) * 1989-05-05 2004-03-10 Genentech Inc. Glycoprotein HormonRezeptor Moleküle. Ihre Verwendungen
US5155218A (en) * 1990-05-08 1992-10-13 Neurogenetic Corporation Dna encoding human 5-ht1d receptors

Also Published As

Publication number Publication date
CA2106061C (en) 2008-10-07
EP1167385A3 (de) 2003-04-16
GEP19991604B (en) 1999-04-29
DK0575357T3 (da) 2002-11-25
US6121016A (en) 2000-09-19
LTIP1631A (en) 1995-07-25
WO1992016620A1 (en) 1992-10-01
JPH06505157A (ja) 1994-06-16
RU2193599C2 (ru) 2002-11-27
FI934023L (fi) 1993-09-14
LV10724B (en) 1995-12-20
CA2106061A1 (en) 1992-09-16
KR100245250B1 (en) 2000-02-15
LV10724A (lv) 1995-06-20
ES2183806T3 (es) 2003-04-01
EP0575357A1 (de) 1993-12-29
FI934023A0 (fi) 1993-09-14
AU671417B2 (en) 1996-08-29
EP1167385B1 (de) 2011-04-13
ATE224446T1 (de) 2002-10-15
DE69232779D1 (de) 2002-10-24
JP3581148B2 (ja) 2004-10-27
DE69232779T2 (de) 2003-01-30
UA43826C2 (uk) 2002-01-15
US5744448A (en) 1998-04-28
AU1251492A (en) 1992-10-21
DE69233805D1 (de) 2011-05-26
EP1167385A2 (de) 2002-01-02
LT3973B (en) 1996-05-27
FI109360B (fi) 2002-07-15
EP0575357B1 (de) 2002-09-18
NO933272D0 (no) 1993-09-14
NO315517B1 (no) 2003-09-15
NO933272L (no) 1993-09-14
US6372711B1 (en) 2002-04-16
MX9203350A (es) 1992-08-01

Similar Documents

Publication Publication Date Title
SE8603966D0 (sv) Fluoroaluminosilicate glass powder for dental glass ionomer cement
ATE464067T1 (de) Bindegewebs wachstumsfaktor (ctgf)
EP0690915A4 (de) Für den vorläufer des für die tumorabstossung verantwortlichen antigens mage-3 kodierendes, isoliertes nukleinsäuremolekül und seine verwendung
ATE142257T1 (de) Modifiziertes baculovirus,herstellung und verwendung als expressionsvektor
DK0440777T3 (da) Neurotrofisk faktor stammende fra hjernen
BR1101088A (pt) Proteìna g do vìrus sincicial respiratório não glicosilada isolada e substancialmente pura
CY1111950T1 (el) 32 ανθρωπινες εκκρινομενες πρωτεϊνες
ATE505486T1 (de) Rezeptor für das menschliche follikel- stimulierende hormon
ATE269355T1 (de) Antigene, die von polyarthritis rheumatoide antikörpern erkannt werden, ihre herstellung und ihre anwendungen
EP1093457A4 (de) Der allgemeinen gamma-kette ähnlicher zytokinrezeptor
NO890008L (no) Forspent konstruksjonselement av sammensatt struktur og fremgangsmaate for fremstilling av dette.
ATE180275T1 (de) Neuartige, physiologisch aktive substanz epimorphin, für sie kodierende gene und antikörper gegen epimorphin
DE3751893D1 (de) Polypeptid und dessen Herstellung
DK0471030T3 (da) Glycoproteinhormonreceptormolekyler
RU93057956A (ru) Рецептор, днк, вектор, клетка, способ получения рецептора, фармацевтическая композиция, способы анализа, способ снижения биоактивности, способы предупреждения спермадогенеза и созревания фолликулов
ES2038642T3 (es) Tratamiento dermico de enfermedades vermiculares del gato con pracicuantel.
EP0659217A4 (de) KLONIERUNG UND EXPRESSION VON DEM -g(b)APP-C100 REZEPTOR.
DE3850933D1 (de) Anticoagulatorisches Protein PP4-X, seine Herstellung und Verwendung.
ATE124722T1 (de) Für das plazentaprotein 9 (pp9) kodierende cdna, ihre isolierung und verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1167385

Country of ref document: EP

EELA Cancelled due to lapse of time